F-star
From Wikipedia, the free encyclopedia
| Industry | Pharmaceutical |
|---|---|
| Headquarters | Cambridge, UK |
| Website | www.f-star.com |
F-star Biotechnology Ltd. was a biotechnology company, founded in Vienna in 2006,[1] with a former main research site in Cambridge, UK. The company was focused on developing bispecific monoclonal antibodies using a modular combinatorial approach that engineers the Fc constant region of an immunoglobulin into a novel antigen-binding site.[2][3]